Results 21 to 30 of about 5,012,650 (270)

Methylmalonic Acid and Vitamin B12 in Patients with Heart Failure.

open access: yesHellenic Journal of Cardiology, 2019
Vitamin B12 deficiency among patients with heart failure (HF) may have been underestimated. High serum levels of methylmalonic acid (MMA) have been identified in several studies as an early indicator of vitamin B12 deficiency. Furthermore, MMA seems to constitute a biomarker of oxidative stress and mitochondrial dysfunction.
K. Polytarchou   +8 more
semanticscholar   +5 more sources

Correlation between toxic organic acid fluctuations and neurodevelopment in patients with methylmalonic acidemia

open access: goldOrphanet Journal of Rare Diseases
Background Methylmalonic acidemia (MMA) is a rare autosomal recessive disorder, that causes multisystem damage by accumulating toxic metabolites. These metabolites, particularly affecting nerve cells, contribute to suboptimal neurodevelopment in MMA ...
I.-Chih Ling   +5 more
doaj   +2 more sources

Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2‐cohort study

open access: yesJournal of Internal Medicine, 2023
Elevated plasma methylmalonic acid (MMA) is reported in patients with established coronary heart disease (CHD) and is considered a marker of vitamin B12 deficiency. Moreover, MMA‐dependent reactions have been linked to alterations in mitochondrial energy
I. Dhar   +14 more
semanticscholar   +1 more source

Case Report: A Case of Late-Onset Combined Methylmalonic Acidemia and Hyperhomocysteinemia Induced by a Vegetarian Diet

open access: yesFrontiers in Pediatrics, 2022
Methylmalonic acidemia is a rare autosomal recessive metabolic disease. However, because of the atypical clinical symptoms, the type of late-onset methylmalonic academia is often misdiagnosed.
Bei Xu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy